Our results constitute a notable contribution to the characterization of the ssDNA-NucS interactions and more generally to the nucleotide excision repair mechanism. The method we developed furthermore constitutes a powerful way to probe DNA/protein intramolecular kinetics.
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The City College of New York, New York, NY, USA, 2 Rutgers University, Piscataway, NJ, USA. Protein design has opened new boundaries in the past decade, particularly in the area of designed enzymes capable of catalyzing reactions not yet observed in nature. We report the design and synthesis of an artificial enzyme capable of activating the class of nitroaromatic anticancer prodrugs typified by CB1954. The enzyme utilizes a synthetic flavin analogue cofactor, p-methoxysafranine, which has a reduction potential preoptimized for efficient nitroreduction. Progress toward optimizing catalytic activity and determination of the three-dimensional structure of this novel enzyme will also be reported.
1050-Plat
Redox Enzymology of Shewanella Oneidensis Cytochrome C Nitrite Reductase Evan T. Judd. Boston University, Boston, MA, USA. Shewanella oneidensis cytochrome c nitrite reductase (soNrfA), a dimeric enzyme that houses five c-type hemes per protomer, carries out the six-electron reduction of nitrite and the two-electron reduction of hydroxylamine. Protein film voltammetry (PFV) has previously been used to study the cytochrome c nitrite reductase from Escherichia coli (ecNrfA) adsorbed to a graphite electrode, revealing catalytic reduction of both nitrite and hydroxylamine substrates by ecNrfA that is characterized by 'boosts' and attenuations in activity depending on the applied potential. Here, we use PFV to investigate the catalytic properties of soNrfA during both nitrite and hydroxylamine turnover and compare those properties to ecNrfA. Distinct differences in both the electrochemical and kinetic characteristics of soNrfA are observed, e.g., all detected electron transfer steps are one-electron in nature, contrary to what has been observed in ecNrfA. Additionally, we find evidence of substrate inhibition during nitrite turnover and negative cooperativity during hydroxylamine turnover, neither of which have previously been observed in any cytochrome c nitrite reductase. Collectively these data provide evidence that during catalysis, potential pathways of communication exist between the individual soNrfA monomers comprising the native homodimer. Enzymes are extraordinary catalysts that actuate nearly all biomolecular processes with speed and specificity. Nevertheless, the physical origins of enzymes' catalytic power remain elusive despite investigations of many enzymes' mechanisms over the last half-century. Ketosteroid isomerase (KSI) is a small and proficient enzyme -accelerating an isomerization reaction~1 trillion-fold over its intrinsic rate in water -that has been employed as a test system to examine the catalytic strategies at Nature's disposal. Electrostatic interactions are broadly purported to play an essential role in catalysis, but this proposal has yet to be experimentally tested in a quantitative fashion. Toward this end, vibrational Stark effect spectroscopy provides a toolkit to measure electric fields in biomolecular environments. By measuring the vibrational Stark effect of an intrinsic probe that mimics the reactive species of KSI's catalytic cycle, we found that KSI's active site focuses an extremely large electric field onto the scissile bond, potentially enabling its speedy chemical conversion through electrostatic interactions. Moreover, we observed a strong correlation between active site electric field and catalytic power across several KSI mutants. These studies are building toward a highly reductionist picture of KSI's catalysis and possibly enzyme catalysis in general.
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Pseudosubstrate Regulation of the Type II P21-Activated Kinases (PAKs) Titus J. Boggon. Yale University School of Medicine, New Haven, CT, USA. The type II p21-activated kinases (PAKs) are key effectors of RHO-family GTPases involved in cell motility, survival and proliferation. There are two sub-groups of PAK kinase, denoted type I (PAK1, PAK2 and PAK3) and type II (PAK4, PAK5 and PAK6). PAK4 is the best-studied type II PAK family member, is widely expressed, and is essential for viability in mice. PAK4 is required for oncogenic or metastatic phenotypes of many cancer cell lines, can promote tumorigenesis and breast cancer cell migration, and is the only PAK that is transforming when overexpressed. Furthermore, a specific PAK4 inhibitor (PF-3758309) has shown efficacy in mouse models of cancer. Using a structure-guided approach, we discovered that type II PAKs are regulated by an N-terminal autoinhibitory pseudosubstrate motif centered on a critical proline residue, and that this regulation occurs independently of activation loop phosphorylation. We determined 6 X-ray crystal structures of either full-length PAK4 or its catalytic domain, that demonstrate the molecular basis for pseudosubstrate binding to the active state with phosphorylated activation loop. We show that full-length PAK4 is constitutively autoinhibited, but mutation of the pseudosubstrate releases this inhibition and causes increased phosphorylation of BAD and cellular morphological changes. We also find that PAK6 is regulated by the pseudosubstrate region, indicating a common type II PAK autoregulatory mechanism. Finally, we find Src SH3, but not b-PIX SH3 can activate PAK4. This clear switch-like 'on-off' regulation mechanism for the type II PAKs is distinct from regulation mechanisms previously observed for the type I PAKs. We therefore provide new understanding for type II PAK regulation. 
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